시너지이노베이션, 46억 규모 자기사채 소각 결정

Synergy Innovation's early retirement of 4.6 billion won in convertible bonds reflects a strategic move to enhance shareholder value and strengthen its financial position ahead of the bond's 2027 maturity. This proactive debt management demonstrates the company's confidence in its financial health and commitment to optimizing its capital structure. The decision underscores how biotech companies are increasingly focusing on shareholder value enhancement through strategic financial operations.